Newsroom
Sorted by: Latest
-
Riassunto: Grid Dynamics accelera la trasformazione AI-native delle aziende grazie alla certificazione del personale e all’implementazione delle piattaforme GAIN
SAN RAMON, Calif.--(BUSINESS WIRE)--Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), un importante fornitore di consulenza per la tecnologia, progettazione di piattaforme e prodotti, nonché servizi di trasformazione digitale basata sull'AI, oggi ha annunciato un importante slancio nell'adozione delle sue soluzioni aziendali di AI agentica. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte uni...
-
Jersey Mike’s Announces Pricing of Its Initial Public Offering
TINTON FALLS, N.J.--(BUSINESS WIRE)--Jersey Mike’s Subs Inc. (“Jersey Mike’s” or the “Company”) today announced the pricing of its initial public offering of 43,478,261 shares of its Class A common stock at a price to the public of $23.00 per share. In addition, existing stockholders (the “Selling Stockholders”) have granted the underwriters a 30-day option to purchase up to an additional 6,521,739 shares of Jersey Mike’s Class A common stock to cover over-allotments at the initial public offer...
-
Grid Dynamics accélère la transformation native de l'IA avec la certification du personnel et le déploiement des plateformes GAIN
SAN RAMON, Californie--(BUSINESS WIRE)--Grid Dynamics Holdings, Inc. (Nasdaq : GDYN) (« Grid Dynamics »), l’un des principaux fournisseurs de services de conseil technologique, d’ingénierie de plateformes et de produits et de services de transformation numérique fondés sur l’IA, annonce aujourd’hui une dynamique significative dans l’adoption de ses solutions d’IA agentique d’entreprise. Les organisations des secteurs de la vente au détail, des services financiers, de la fabrication, des CPG et...
-
Resumen: Grid Dynamics acelera su transformación empresarial nativa de IA con la certificación de competencias laborales y el despliegue de plataformas GAIN
SAN RAMÓN, California--(BUSINESS WIRE)--Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), proveedor líder de asesoramiento en tecnología, diseño de plataformas y productos, y servicios de transformación digital orientada a IA, anunció hoy un gran avance con la adopción de sus soluciones de IA agéntica empresarial. El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducción es solamente un medio de ayuda y deberá ser comparada con el texto en id...
-
Grid Dynamics beschleunigt die KI-native Transformation von Unternehmen durch Mitarbeiterzertifizierungen und Rollout von GAIN-Plattformen
SAN RAMON, Kalifornien, USA--(BUSINESS WIRE)--Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) („Grid Dynamics“), ein führender Partner für Technologieberatung, Plattform- und Produktentwicklung sowie KI-gesteuerte Dienstleistungen für die digitale Transformation, gab heute bekannt, dass die Einführung seiner agentischen KI-Lösungen für Unternehmen deutlich an Fahrt gewonnen hat. Immer mehr Unternehmen aus den Bereichen Einzelhandel, Finanzdienstleistungen, Fertigung, Konsumgüter (CPG) und Logistik...
-
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Sanara MedTech Inc. (NASDAQ: SMTI) to MiMedx Group, Inc. for $33.00 in cash and 0.4735 shares of MiMedx common stock for each share of Sanara common stock. Halper Sadeh encourages Sanara shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The inves...
-
NorthWestern Energy Reports Second Quarter 2026 Financial Results
BUTTE, Mont. & SIOUX FALLS, S.D.--(BUSINESS WIRE)--NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (Nasdaq: NWE) reported financial results for the Second Quarter of 2026. Net income for the period was $25.0 million, or $0.40 per diluted share, as compared with net income of $21.2 million, or $0.35 per diluted share, for the same period in 2025. This increase was primarily due to new rates and retail volumes. These were offset in part by operating, administrative, and general costs, i...
-
Afya Announces Appointment of Marcelo Ken Suhara as the Chair Member of the Audit, Risks and Ethics Committee
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee. Mr. Suhara, who currently serves as an independent member of Afya’s Board of Directors and a member of the Audit, Risks and Ethics Committee and the Audit Committee financia...
-
KBRA Assigns Preliminary Ratings to Bayview Opportunity Master Fund VII Trust 2026-CES2 (BVCES 2026-2)
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 20 classes of mortgage-backed notes from Bayview Opportunity Master Fund VII Trust 2026-CES2 (BVCES 2026-2). Bayview Opportunity Master Fund VII Trust 2026-CES2 (BVCES 2026-2) is a $404.6 million RMBS transaction, as of the cut-off date, sponsored by Bayview Asset Selector VII, LLC and Loan Funding Structure VII LLC, and consists entirely of newly originated closed-end second lien mortgages (CES; 100.0%). The underlying pool is six...
-
ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA® Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small Cell Lung Cancer
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a vertically integrated commercial-stage biotechnology company, today announced that the Emirates Drug Establishment (EDE) of the United Arab Emirates (UAE) has granted Marketing Authorization for ANKTIVA® (nogapendekin alfa inbakicept) across two indications. The authorization covers ANKTIVA 0.4 mg in combination with BCG for the treatment of adult patients with BCG-unresponsive NMIBC, and ANKTIVA 1.2 mg in combination wit...